Rights issue attached to capital raising???, page-3

What an embarrassment it would be raising funds down at these levels .... that would also confirm AstraZeneca aren't paying the milestone payment anytime soon

What a resume JF is clocking up - booted from ASX300; no upfront or milestone payments from any of the big pharma deals touted by her in over 4 years; no DEP phase 2 trial data 8 years later; and now perhaps a CR down here at these levels ?

Even if the net operating outflows for the June quarter were approximately double the March 23 quarter, they should still have circa $30 million in the bank so a raise at these levels would demonstrate IMO that there is no $ incoming in our immediate future ... how sad that would be after all the promises made / prospective deals touted

I would support a T/O @ $1 over and above a CR - just sayin'